Visualizing nationwide variation in medicare Part D prescribing patterns

Abstract

BackgroundTo characterize the regional and national variation in prescribing patterns in the Medicare Part D program using dimensional reduction visualization methods.MethodsUsing publicly available Medicare Part D claims data, we identified and visualized regional and national provider prescribing profile variation with unsupervised clustering and t-distributed stochastic neighbor embedding (t-SNE) dimensional reduction techniques. Additionally, we examined differences between regionally representative prescribing patterns for major metropolitan areas.ResultsDistributions of prescribing volume and medication diversity were highly skewed among over 800,000 Medicare Part D providers. Medical specialties had characteristic prescribing patterns. Although the number of Medicare providers in each state was highly correlated with the number of Medicare Part D enrollees, some states were enriched for providers with > 10,000 prescription claims annually. Dimension-reduction, hierarchical clustering and t-SNE visualization of drug- or drug-class prescribing patterns revealed that providers cluster strongly based on specialty and sub-specialty, with large regional variations in prescribing patterns. Major metropolitan areas had distinct prescribing patterns that tended to group by major geographical divisions.ConclusionsThis work demonstrates that unsupervised clustering, dimension-reduction and t-SNE visualization can be used to analyze and visualize variation in provider prescribing patterns on a national level across thousands of medications, revealing substantial prescribing variation both between and within specialties, regionally, and between major metropolitan areas. These methods offer an alternative system-wide and pattern-centric view of such data for hypothesis generation, visualization, and pattern identification.Electronic supplementary materialThe online version of this article (10.1186/s12911-018-0670-2) contains supplementary material, which is available to authorized users.

Overactive bladder medication: Anticholinergics versus mirabegron by specialty

“…11 More broadly, prescribing variation in PDP data has been described with provider clusters rooted in specialty/sub-specialty and regions. 15 Prescribing patterns within and between regions depend on a myriad of factors including demographics, socioeconomics, and local formularies. Sources of regional prescribing variation of OAB medication and its sequelae warrants further investigation.…”

The role of county-level socioeconomic status on brand-name prescriptions in Medicare part D

“…Although we controlled for three variables in our final model analysis, the possibility of other confounders that contribute to a higher likelihood of brand-name drugs exists. An estimated 50% of individuals enrolled in Medicare Part D also have supplemental or private insurance for medication coverage, therefore, overall claims may differ from those found in Medicare Part D. [ 32 ] Additionally, we were unable to omit brand-name drugs for which no approved generic version exists. Nevertheless, previous work suggests that therapeutic substitution, or the practice of promoting the prescription of in-class generic drugs, could generate substantial savings for when no approved version exists for a brand-name drug.…”

Investigating Racial Disparities in Drug Prescriptions for Patients with Endometriosis

“…The use of ATC level 3 drug classes enables us to quickly and accurately pull relevant drugs based on their pharmacological functions while remaining robust to the fact that providers in different states may vary in their precise prescription patterns 42,43 . However, ATC medication classes are intended to reflect the drug indication, which may not always be consistent with why the drug was prescribed.…”